Topic

Articles

Bringing clinical trials to patients’ homes can address existing site-based challenges.

Patient-Tested Practices for In-Home Trials

Four lessons learned from changes made by research sites during the pandemic to drive long-term success.

Accelerating Research Site Operations: Lessons from the University of Louisville

While it's important to note that there are areas where the industry can improve, there are unique opportunities of improvement for specific types of sites and the number of studies conducted there. 

Identify Opportunities to Improve Diversity Recruitment

DSAT Methodology

Building authentic trust lays at the heart of creating more patient-centric trials.

Steps Toward Diversity in Clinical Trials: Building Authentic Trust

Kenneth Getz is a senior research fellow at the Tufts Center for the Study of Drug Development.

Comparing late-stage COVID-19 vaccine trials to historical practices.

Investigative Site Placement Practices to Support Operation Warp Speed

Findings from a Tufts study examining the effects of COVID-19 on clinical trials.

COVID-19 and Its Impact on the Future of Clinical Trial Execution

Lessons from six months of conducting clinical trials during the COVID-19 pandemic

Where Do We Go From Here?

Hassan Kadhim, Director, Global Head of Clinical Trial Business Capabilities, Clinical Innovation & Industry Collaborations at Bristol Myers Squibb, discusses his perspectives on how the pandemic has shifted clinical innovation.


COVID Shifts Clinical Innovation in Big Pharma

Recognizing pre-pandemic pain points, such as patient engagement and protocol development, could lead to post-pandemic trial success. 

Investigative Sites